Logo image of AEYE

AUDIOEYE INC (AEYE) Stock Fundamental Analysis

USA - NASDAQ:AEYE - US0507342014 - Common Stock

13.23 USD
-0.4 (-2.93%)
Last: 9/19/2025, 8:00:00 PM
13.08 USD
-0.15 (-1.13%)
After Hours: 9/19/2025, 8:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AEYE. AEYE was compared to 281 industry peers in the Software industry. AEYE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AEYE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AEYE had negative earnings in the past year.
AEYE had a positive operating cash flow in the past year.
AEYE had negative earnings in each of the past 5 years.
In multiple years AEYE reported negative operating cash flow during the last 5 years.
AEYE Yearly Net Income VS EBIT VS OCF VS FCFAEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -12.27%, AEYE is doing worse than 66.79% of the companies in the same industry.
Looking at the Return On Equity, with a value of -56.62%, AEYE is doing worse than 71.79% of the companies in the same industry.
Industry RankSector Rank
ROA -12.27%
ROE -56.62%
ROIC N/A
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
AEYE Yearly ROA, ROE, ROICAEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

AEYE has a better Gross Margin (79.16%) than 78.21% of its industry peers.
AEYE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AEYE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
AEYE Yearly Profit, Operating, Gross MarginsAEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

2

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEYE has been increased compared to 1 year ago.
Compared to 5 years ago, AEYE has more shares outstanding
AEYE has a better debt/assets ratio than last year.
AEYE Yearly Shares OutstandingAEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AEYE Yearly Total Debt VS Total AssetsAEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

AEYE has an Altman-Z score of 0.67. This is a bad value and indicates that AEYE is not financially healthy and even has some risk of bankruptcy.
AEYE has a Altman-Z score of 0.67. This is in the lower half of the industry: AEYE underperforms 68.21% of its industry peers.
The Debt to FCF ratio of AEYE is 9.39, which is on the high side as it means it would take AEYE, 9.39 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.39, AEYE perfoms like the industry average, outperforming 51.07% of the companies in the same industry.
A Debt/Equity ratio of 1.74 is on the high side and indicates that AEYE has dependencies on debt financing.
AEYE's Debt to Equity ratio of 1.74 is on the low side compared to the rest of the industry. AEYE is outperformed by 79.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 9.39
Altman-Z 0.67
ROIC/WACCN/A
WACC11.38%
AEYE Yearly LT Debt VS Equity VS FCFAEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

AEYE has a Current Ratio of 1.10. This is a normal value and indicates that AEYE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.10, AEYE is doing worse than 67.50% of the companies in the same industry.
A Quick Ratio of 1.10 indicates that AEYE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.10, AEYE is doing worse than 66.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
AEYE Yearly Current Assets VS Current LiabilitesAEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

AEYE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.43%.
Looking at the last year, AEYE shows a quite strong growth in Revenue. The Revenue has grown by 18.52% in the last year.
Measured over the past years, AEYE shows a very strong growth in Revenue. The Revenue has been growing by 26.73% on average per year.
EPS 1Y (TTM)-46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
Revenue 1Y (TTM)18.52%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%16.38%

3.2 Future

AEYE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.53% yearly.
AEYE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.82% yearly.
EPS Next Y63.86%
EPS Next 2Y60.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.85%
Revenue Next 2Y14.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AEYE Yearly Revenue VS EstimatesAEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
AEYE Yearly EPS VS EstimatesAEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

AEYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 65.51, AEYE can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as AEYE.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, AEYE is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 65.51
AEYE Price Earnings VS Forward Price EarningsAEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

AEYE's Enterprise Value to EBITDA is on the same level as the industry average.
AEYE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 119.15
EV/EBITDA 195.33
AEYE Per share dataAEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

AEYE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AEYE's earnings are expected to grow with 60.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.53%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AEYE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AUDIOEYE INC

NASDAQ:AEYE (9/19/2025, 8:00:00 PM)

After market: 13.08 -0.15 (-1.13%)

13.23

-0.4 (-2.93%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners40.68%
Inst Owner Change-7.65%
Ins Owners32.96%
Ins Owner Change6.76%
Market Cap164.18M
Analysts81.82
Price Target22.64 (71.13%)
Short Float %7.34%
Short Ratio5.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-695.49%
Min EPS beat(2)-1207.19%
Max EPS beat(2)-183.8%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.02%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-1.94%
Revenue beat(12)0
Avg Revenue beat(12)-2.01%
Revenue beat(16)0
Avg Revenue beat(16)-1.8%
PT rev (1m)-0.89%
PT rev (3m)-0.89%
EPS NQ rev (1m)-900%
EPS NQ rev (3m)-900%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.22%
Revenue NY rev (1m)-2.49%
Revenue NY rev (3m)-2.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 65.51
P/S 4.29
P/FCF 119.15
P/OCF 49.92
P/B 22.34
P/tB N/A
EV/EBITDA 195.33
EPS(TTM)-0.41
EYN/A
EPS(NY)0.2
Fwd EY1.53%
FCF(TTM)0.11
FCFY0.84%
OCF(TTM)0.27
OCFY2%
SpS3.08
BVpS0.59
TBVpS-0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.27%
ROE -56.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.16%
FCFM 3.6%
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 1.74
Debt/FCF 9.39
Debt/EBITDA 14.23
Cap/Depr 57.27%
Cap/Sales 5%
Interest Coverage N/A
Cash Conversion 366.67%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 0.67
F-Score4
WACC11.38%
ROIC/WACCN/A
Cap/Depr(3y)70.6%
Cap/Depr(5y)93.23%
Cap/Sales(3y)5.53%
Cap/Sales(5y)5.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
EPS Next Y63.86%
EPS Next 2Y60.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.52%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%16.38%
Revenue Next Year14.85%
Revenue Next 2Y14.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year632.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y313.57%
OCF growth 3YN/A
OCF growth 5YN/A